MCL
MRK icon

MIRAMONTES CAPITAL, LLC’s Merck MRK Stock Holding History

MIRAMONTES CAPITAL, LLC’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264K Sell
2,051
-61
-3% -$7.14K 0.08% 122
2026
Q1 		$254K Sell
2,112
-17
-0.8% -$1.96K 0.09% 106
2025
Q4 		$224K Buy
+2,129
New +$200K 0.08% 112

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIRAMONTES CAPITAL, LLC's MRK Position: Q2 2026 in Review

MIRAMONTES CAPITAL, LLC reduced its Merck (MRK) stake by 2.9% in Q2 2026, selling an estimated $7.14K and leaving 2,051 shares worth $264K. The position accounts for 0.08% of the portfolio, ranked #122.

MIRAMONTES CAPITAL, LLC first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,838 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • MIRAMONTES CAPITAL, LLC held 2,051 shares of Merck worth $264K as of Q2 2026.
  • MIRAMONTES CAPITAL, LLC sold 61 Merck shares in Q2 2026, an estimated $7.14K.
  • Merck made up 0.08% of MIRAMONTES CAPITAL, LLC's portfolio in Q2 2026, its #122 holding.
  • MIRAMONTES CAPITAL, LLC first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 3,838 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on MIRAMONTES CAPITAL, LLC's 13F filing for Q2 2026, filed 9 Sep 2026.